Please select the option that best describes you:

How will the PROSPECT trial presented at ASCO 2023 change your current management of early rectal cancer?  

Especially as the study was done before the adoption of total neoadjuvant therapy



Answer from: Radiation Oncologist at Academic Institution
Comments
Medical Oncologist at Joliet Oncology Hematology Associates
Thank you for an excellent commentary.
Medical Oncologist at NYU Winthrop Hospital
Prospect study:- MRI pelvis was not done. EUS wa...
Radiation Oncologist at Brigham and Women's Hospital
An MRI of the pelvis was done 84% off patients (Ta...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at OSF Saint Paul Medical Center
Thanks for your input, was important.
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
Thank you Dr. @Vatsal B. Patel. In the PROSPECT tr...
Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
Thank you for clarifying your question, Dr. @Patel...
Sign in or Register to read more